These results suggest that, although KRAS, APC, SMAD4, and TP53 gene mutations are essential events for colorectal cancer development33, the downstream effects of their mutation is more evident for the protein upstream in the signaling pathway. This evidence concerns the gene KRAS and colorectal cancer.